News

Upcoming Deadline for Expression of Interest Submission NGCAT (Next Generation Combat Aircraft Technologies)

Published on | 1 year ago

Programmes Defence EDF NATO-EDA Space

We would like to remind you that the deadline for submitting your Expression of Interest (EoI) for the thematic call for research and development proposals in the field of Next Generation Combat Air Technologies (NGCAT) is fast approaching. The final date for submission is 7 June 2024.

If you are interested in participating, we encourage you to complete and submit your EoI on the NGCAT-platform, as soon as possible. Further information on the NGCAT call can be found on the DEFRA website.

We would also like to draw your attention to an updated version of the FAQ, which includes guidelines to classify a company as a small, medium-size or large enterprise. 

Should you have any questions or need further assistance, please do not hesitate to reach out to NCP Flanders or directly to ngcat@belspo.be.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1738 articles available search in articles 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.